SNEX Stock Analysis: Stonex | NASDAQ
Capital Markets | NASDAQ, USA | Market Cap: 10.789m USD | 12M Return: 92.8% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 131M
EPS Trend: 89.9%
Qual. Beats: 2
Rev. Trend: 98.6%
Qual. Beats: 11
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
StoneX Group Inc. (NASDAQ: SNEX) is a global financial services firm that connects clients across the commercial, institutional, retail, and payments sectors to a broad market ecosystem spanning the U.S., Europe, South America, the Middle East, and Asia. The company operates through four segments: Commercial (risk management, hedging, physical commodities trading, and execution/clearing of exchange-traded and OTC products), Institutional (acting as a dealer in fixed income securities for asset managers, broker-dealers, and insurance companies), Self-Directed/Retail (forex, precious metals, CFDs, spread bets, and wealth management, including online bullion sales), and Payments.
The firm is headquartered in New York, was founded in 1924, and rebranded from INTL FCStone Inc. to StoneX Group Inc. in July 2020. As a large-cap Financials company classified within the Investment Banking & Brokerage sub-industry, StoneX operates a diversified business model that spans execution, clearing, physical commodity logistics, and retail trading platforms, distinguishing it from pure-play brokers by combining traditional securities services with global commodities trading and correspondent payments infrastructure.
- Payments segment revenue accelerates on cross-border B2B acquisitions
- Net interest income expands with Fed rate hikes and securities portfolio growth
- Commercial hedging and brokerage volumes track global commodity volatility
| Net Income: 462.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 18.33 > 1.0 |
| NWC/Revenue: -1.39% < 20% (prev 8.24%; Δ -9.63% < -1%) |
| CFO/TA 0.15 > 3% & CFO 7.97b > Net Income 462.4m |
| Net Debt (36.5b) to EBITDA (2.49b): 14.65 < 3 |
| Current Ratio: 0.88 > 1.5 & < 3 |
| Outstanding Shares: last quarter (81.5m) vs 12m ago 9.98% < -2% |
| Gross Margin: 2.33% > 18% (prev 1.81%; Δ 0.52% > 0.5%) |
| Asset Turnover: 358.8% > 50% (prev 393.3%; Δ -34.46% > 0%) |
| Interest Coverage Ratio: 1.34 > 6 (EBIT TTM 2.41b / Interest Expense TTM 1.80b) |
| A: -0.04 (Total Current Assets 15.3b - Total Current Liabilities 17.4b) / Total Assets 53.6b |
| B: 0.04 (Retained Earnings 2.01b / Total Assets 53.6b) |
| C: 0.06 (EBIT TTM 2.41b / Avg Total Assets 42.5b) |
| D: 0.05 (Book Value of Equity 2.70b / Total Liabilities 50.9b) |
| Altman-Z'' = 0.30 = B |
| DSRI: 1.27 (Receivables 13.6b/8.64b, Revenue 152b/123b) |
| GMI: 0.78 (GM 1.81% / 2.33%) |
| AQI: 2.56 (AQ_t 0.71 / AQ_t-1 0.28) |
| SGI: 1.24 (Revenue 152b / 123b) |
| TATA: -0.14 (NI 462.4m - CFO 7.97b) / TA 53.6b) |
| Beneish M = -1.93 (Cap -4..+1) = B |
As of July 04, 2026, the stock is trading at USD 120.55 with a total of 808,500 shares traded. Over the past week, the price has changed by -12.19%, over one month by +10.53%, over three months by +40.81% and over the past year by +92.76%.
Current recommended Stop Loss: 112.70 (which is 6.5% or 1.1 ATR below the current price).
Stonex has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy SNEX.
- StrongBuy: 2
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 123 | 2% |
P/E Trailing = 24.3524
P/E Forward = 9.7943
P/S = 0.0717
P/B = 3.9968
Revenue TTM = 152b USD
EBIT TTM = 2.41b USD
EBITDA TTM = 2.49b USD
Long Term Debt = 21.0b USD (from longTermDebt, last quarter)
Short Term Debt = 17.4b USD (from shortTermDebt, last quarter)
Debt = 38.6b USD (corrected: LT Debt 21.0b + ST Debt 17.4b) + Leases 219.3m
Net Debt = 36.5b USD (calculated: Debt 38.6b - CCE 2.12b)
Enterprise Value = 47.3b USD (10.8b + Debt 38.6b - CCE 2.12b)
Interest Coverage Ratio = 1.34 (Ebit TTM 2.41b / Interest Expense TTM 1.80b)
EV/FCF = 5.99x (Enterprise Value 47.3b / FCF TTM 7.90b)
FCF Yield = 16.70% (FCF TTM 7.90b / Enterprise Value 47.3b)
FCF Margin = 5.18% (FCF TTM 7.90b / Revenue TTM 152b)
Net Margin = 0.30% (Net Income TTM 462.4m / Revenue TTM 152b)
Gross Margin = 2.33% ((Revenue TTM 152b - Cost of Revenue TTM 149b) / Revenue TTM)
Gross Margin QoQ = 2.75% (prev 2.29%)
Tobins Q-Ratio = 0.88 (Enterprise Value 47.3b / Total Assets 53.6b)
Interest Expense / Debt = 4.67% (Interest Expense 1.80b / Debt 38.6b)
Taxrate = 23.80% (144.4m / 606.8m)
NOPAT = 1.84b (EBIT 2.41b * (1 - 23.80%))
Current Ratio = 0.88 (Total Current Assets 15.3b / Total Current Liabilities 17.4b)
Debt / Equity = 14.32 (Debt 38.6b / totalStockholderEquity, last quarter 2.70b)
Debt / EBITDA = 14.65 (Net Debt 36.5b / EBITDA 2.49b)
Debt / FCF = 4.62 (Net Debt 36.5b / FCF TTM 7.90b)
Total Stockholder Equity = 2.39b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.09% (Net Income 462.4m / Total Assets 53.6b)
RoE = 19.31% (Net Income TTM 462.4m / Total Stockholder Equity 2.39b)
RoCE = 10.28% (EBIT 2.41b / Capital Employed (Equity 2.39b + L.T.Debt 21.0b))
RoIC = 3.56% (NOPAT 1.84b / Invested Capital 51.5b)
WACC = 4.76% (E(10.8b)/V(49.4b) * Re(9.09%) + D(38.6b)/V(49.4b) * Rd(4.67%) * (1-Tc(0.24)))
Discount Rate = 9.09% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 100.00 | Cagr: 27.79%
[DCF] Terminal Value 75.44% ; FCFF base≈7.90b ; Y1≈7.93b ; Y5≈8.40b
[DCF] Fair Price = 1.19k (EV 131b - Net Debt 36.5b = Equity 94.1b / Shares 79.3m; r=8.35% [WACC [floored]]; 5y FCF grow 0.0% → 2.50% )
EPS Correlation: 89.90 | EPS CAGR: 23.74% | SUE: 3.97 | # QB: 2
Revenue Correlation: 98.62 | Revenue CAGR: 45.17% | SUE: 1.88 | # QB: 11
EPS current Year (2026-09-30): EPS=6.41 | Chg30d=+15.70% | Revisions=+20% | GrowthEPS=+59.7% | GrowthRev=-35.9%
EPS next Year (2027-09-30): EPS=6.65 | Chg30d=+13.48% | Revisions=+20% | GrowthEPS=+3.7% | GrowthRev=+0.0%